Sector export playbook ยท HS 28-38

Sri Lanka Chemicals exports
where capability meets demand

Explore Sri Lanka's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.

LKAHS 28-3822 products2024 trade year
Sector exports$3.5M2024 reported value
Products22Qualifying HS6 products
Buyer markets28Markets represented
Average CAGR+6.2%Product-level growth signal
Global sector size$426.7BReported buyer imports

Chemicals capability

How strong is Sri Lanka in this sector?

Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.

Sector footprint

$3.5M in exports

Reported chemicals exports in 2024 across 22 qualifying HS6 products.

Global demand

$426.7B buyer imports

The sector's reported buyer import base provides context for product and market prioritization.

How to use the guide

Find the next credible move

Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.

Product portfolio

Which products anchor the sector?

Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.

ProductGlobal sizeYour exportsOpportunityCAGRMarketsShare
HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale$301.0B$546.5K$113.7B+11.1%20+0.0%
HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824$29.3B$382.9K$20.1B+16.7%11+0.0%
HS 300220Vaccines: for human medicine$10.4B$168.9$10.8B-21.8%3+0.0%
HS 330210Odoriferous substances and mixtures: of a kind used in the food or drink industries$7.9B$2.1K$10.7B-2.1%3+0.0%
HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)$18.2B$2.5M$8.0B+25.8%4+0.0%
HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale$8.2B$1.2K$6.1B-11.3%4+0.0%
HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material$12.4B$8.2K$4.6B+9.9%3+0.0%
HS 330300Perfumes and toilet waters$7.0B$6.3K$3.6B+12.4%2+0.0%
HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions$5.5B$395.4$3.2B+33.7%1+0.0%
HS 300215Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale$8.0B$18.6$2.9B-5.4%1+0.0%
HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)$3.8B$6.9K$2.2B+10.9%2+0.0%
HS 370790Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use$2.2B$361.0$1.8B-2.8%1+0.0%
HS 381512Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included$1.4B$51.3$1.7B-4.4%1+0.0%
HS 284690Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals$1.4B$107.7$1.5B+3.7%1+0.0%
HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale$1.2B$111.2$1.4B-3.2%1+0.0%
HS 321590Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid$674.3M$0.7$1.1B-29.2%1+0.0%
HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products$2.7B$1.3$1.0B+5.6%1+0.0%
HS 310210Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution$2.0B$7.8K$1.0B-0.4%1+0.0%
HS 382319Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids)$669.2M$1.9K$1.0B+1.8%1+0.0%
HS 320611Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter$1.1B$2.2K$997.2M-10.0%1+0.0%
HS 294190Antibiotics: n.e.c. in heading no. 2941$883.6M$25.0K$990.0M+4.9%1+0.0%
HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934$895.5M$0.5$959.0M-57.3%1+0.0%

Best markets

Where does sector demand concentrate?

Markets are ranked by calculated opportunity across the qualifying products in this sector view.

USA

USA, Puerto Rico and US Virgin Islands

8 products represented in the sector.

$38.1B$110.0B reported buyer imports

CHE

Switzerland, Liechtenstein

3 products represented in the sector.

$33.9B$54.6B reported buyer imports

BEL

Belgium

3 products represented in the sector.

$16.1B$27.1B reported buyer imports

CHN

China

5 products represented in the sector.

$14.2B$33.3B reported buyer imports

GBR

United Kingdom

5 products represented in the sector.

$10.8B$21.8B reported buyer imports

SVN

Slovenia

1 products represented in the sector.

$9.7B$7.6B reported buyer imports

DEU

Germany

5 products represented in the sector.

$9.7B$37.6B reported buyer imports

CAN

Canada

4 products represented in the sector.

$7.5B$11.6B reported buyer imports

MEX

Mexico

3 products represented in the sector.

$7.3B$5.7B reported buyer imports

FRA

France

4 products represented in the sector.

$6.6B$17.9B reported buyer imports

NLD

Netherlands

1 products represented in the sector.

$5.3B$10.5B reported buyer imports

ESP

Spain

1 products represented in the sector.

$5.2B$11.9B reported buyer imports

Growth stars

Which products show the strongest growth?

Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.

ProductAverage CAGROpportunityMarkets
HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions+33.7%$3.2B1
HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)+25.8%$8.0B4
HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824+16.7%$20.1B11
HS 330300Perfumes and toilet waters+12.4%$3.6B2
HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale+11.1%$113.7B20
HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)+10.9%$2.2B2
HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material+9.9%$4.6B3
HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products+5.6%$1.0B1
HS 294190Antibiotics: n.e.c. in heading no. 2941+4.9%$990.0M1
HS 284690Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals+3.7%$1.5B1

Diversification opportunities

Which products reach the widest buyer base?

Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.

HS 300490

Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale

20 markets$113.7B calculated opportunity

HS 382499

Chemical products, mixtures and preparations: n.e.c. heading 3824

11 markets$20.1B calculated opportunity

HS 330499

Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)

4 markets$8.0B calculated opportunity

HS 300439

Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale

4 markets$6.1B calculated opportunity

HS 300220

Vaccines: for human medicine

3 markets$10.8B calculated opportunity

HS 330210

Odoriferous substances and mixtures: of a kind used in the food or drink industries

3 markets$10.7B calculated opportunity

HS 382200

Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material

3 markets$4.6B calculated opportunity

HS 330300

Perfumes and toilet waters

2 markets$3.6B calculated opportunity

Frequently asked questions

Using the Chemicals export playbook

Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.

How strong is Sri Lanka in this sector?

Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.

What are growth stars?

Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.

What does diversification mean here?

Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.

Data source

OECD trade statistics with CEPII context

OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.